Randomized Cross Over Study to Assess Efficacy and Safety of BDP/FF and Glycopyrrolate

NCT01476813 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

281

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG: Glycopyrrolate
DRUG: Glycopyrrolate
DRUG: Glycopyrrolate
DRUG: Comparator

Sponsor

Chiesi Farmaceutici S.p.A.